Article Text

Download PDFPDF

Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection

Statistics from Altmetric.com

Hall EM, Yin DE, Goyal RK, et al. Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection. J ImmunoTher Cancer 2021;9:e001225. doi: 10.1136/jitc-2020-001225

This article has been corrected since it first published. The provenance and peer review statement has been added.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.